期刊文献+

小鼠内耳3种溶酶体酶的定位及酶缺乏时的听力损害 被引量:2

Orientation of three lysosomal enzymes in the mouse inner ear and hearing loss in enzyme gene deficiency
下载PDF
导出
摘要 目的:研究溶酶体神经氨酸酶(neuraminidase,Neu1)、保护蛋白/组织蛋白酶A(protective protein/cahepsinA,PPCA)和β-乳糖苷酶(β-galactosidase,β-al)在小鼠内耳的分布及相互影响,观察各自酶缺乏时的听功能改变。方法:分别使用出生后2个月的野生型(Neu1^+/+,PPCA^+/+和β-gal^+/+)小鼠各6只,年龄配对的酶基因缺乏(Neu1^-/-,PPCA^-/-和β-gal^-/-)小鼠作对照,每组6只。用听性脑干反应(ABR)测试短声(click)、短音8,16和32kHz听阈,经活体心脏灌注固定、听泡石蜡包埋和耳蜗连续切片,用免疫组织化学方法确定上述3种酶在内耳的分布情况。结果:Neu1,PPCA和β-gal在内耳不同部位的分布相类似。Neu1最强的染色主要在螺旋神经节细胞、螺旋韧带、螺旋缘、前庭神经节细胞及壶腹嵴、球囊和椭园囊感觉毛细胞,较弱的染色分布于血管纹和Corti器内、外毛细胞及支持细胞;PPCA和β-gal在螺旋神经节和前庭神经节细胞有较强的染色,血管纹、螺旋韧带、螺旋缘和Corti器内、外毛细胞及支持细胞呈较弱的染色反应;各自酶缺乏时内耳免疫染色消失。Neu1^-/-小鼠内耳PPCA和β-gal,以及β-gal^-/-小鼠Neu1和PPCA免疫反应各自无明显改变,而PPCA^-/-小鼠Neu1染色反应消失,β-gal仅存极弱的染色反应。Neu1^-/-,PPCA^-/-和β-gal^-/-小鼠听阈分别较其野生型提高约60~69dB,40~48dB和7~10dB。结论:Neu1,PPCA及β-gal分布于内耳不同组织和细胞,3种酶也以1种多酶复合物的形式存在于内耳;各自酶基因缺乏可致不同程度的听力损害。 Objective To determine the distribution and influence of lysosomal neuraminidase ( Neu1 ), protective protein/cathepsin A (PPCA) and β-galactosidase (β-gal) in the inner ear of the mouse, and to observe their auditory alterations in enzyme deficiency. Methods Six wild type (2 months postnatal) (Neu1^+/+, PPCA^+/+ and β-gal^+/+ ) mice were used, and Neu1, PPCA and β-gal homozygous (Neu1^-/- , PPCA^-/- and β-gal^-/- ) mice at the same age used as control in this experiment. The auditory thresholds were examined through the auditory brainstem responses (ABR) to click, which tone pips were 8, 16, and 32 kHz. The mice were intracardically perfused with 4% paraformaldehyde. The bulla were further fixed in 4% paraformaldehyde, processed and sectioned with paraffin embedded method. Immunohistochemistry was used to determine the cellular localizations of Neu1, PPCA, and β-gal in the inner ear. Results There was a similar distributive pattern of Neu1, PPCA and β-gal in the inner ear. Neu1 intense staining was observed in the cochlear spiral ganglion cells, spiral limbus, spiral ligament, vestibular ganglion cells, cristae, maculae hair cells, and weak staining in inner hair cells, outer hair cells, supplying cells of the organ of Corti and stria vascularis. The intense staining of PPCA and β-gal were observed in the spiral ganglion and vestibular gangli in the spiral limbus, spiral ligament, stria vascularis and organ of Corti. The on cells, and weak staining inner ear exhibited no staining when Neu1, PPCA and β-gal were deficient, respectively. A positive staining of PPCA and β-gal was presented in Neu1^-/- mice, and as well as Neu1 and PPCA in β-gal^-/- mice. However, the staining of Neu1 was not presented, and only very weak staining of β-gal in PPCA^-/- mice. The auditory thresholds of Neu1, PPCA, and β-gal mice were elevated for 60 -69 dB, 40 -48 dB, and 7 - 10 dB above those of wildtype littermates, respectively. Conclusion Neu1, PPCA and β-gal are distributed in the inner ear of mouse, and the three enzymes also form a lysosomal multi-enzyme complex in the inner ear. The respective enzyme deficiencies can induce the hearing the loss of different levels.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2006年第1期79-84,共6页 Journal of Central South University :Medical Science
关键词 溶酶体酶 神经氨酸酶 保护蛋白/组织蛋白酶A Β-半乳糖苷酶 内耳 小鼠 lysosome neuraminidase ( Neu1 ) protective protein/cathepsin A (PPCA) β-galactosidase (β-gal) inner ear deafness mouse
  • 相关文献

参考文献17

  • 1Pshezhetsky AV,Ashmarina M.Lysosomal multienzyme complex:biochemistry,genetics and molecular pathophysiology[J].Prog Nucleic Acid Res Mol Biol,2001,69(1):81-115.
  • 2Bonten EJ,Arts WE,Beck M,et al.Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis[J].Hum Mol Genet,2000,9(18):2715-2725.
  • 3Rodiguez Criado G,Pshezhetsky AV,Rodriguez Becerra A,et al.Clinical variability of type II sialidosis by C808T mutation[J].Am J Med Genet A,2003,116(4):368-371.
  • 4Okamura-Oho Y,Zhang S,Callahan JW.The biochemistry and clinical features of galactosialidosis[J].Biochim Biophys Acta,1994,1225(3):244-254.
  • 5Gorlin RJ.Genetic hearing loss associated with endocrine and metabolic disorders[A].Gorlin RJ,Toriello HV,Cohen MM,ed.Hereditary hearing loss and its syndromes[M].New York:Oxford University Press,1999.318-354.
  • 6de Geest N,Bonten E,Mann L,et al.Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice[J].Hum Mol Genet,2002,11(12):1455-1464.
  • 7Hahn CN,del Pilar Martin M,Schroder M,et al.Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid β-galactosidase[J].Hum Mol Genet,1997,6(2):205-211.
  • 8Zhou XY,Morreau H,Rottier R,et al.Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells[J].Genes Dev,1995,9(21):2623-2634.
  • 9Wu X,Gao J,Guo Y,et al.Hearing threshold elevation precedes hair-cell loss in prestin knockout mice[J].Mol Brain Res,2004,126(1):30-37.
  • 10Rottier RJ,Hahn CN,Mann LW,et al.Lack of PPCA expression only partially coincides with lysosomal storage in galactosialidosis mice:indirect evidence for spatial requirement of the catalytic rather than the protective function of PPCA[J].Hum Mol Genet,1998,7(11):1787-1794.

同被引文献27

  • 1BEVAN S, WINTER J. Nerve growth factor (NGF) differentiallyregulates the chemosensitivity of adult rat cultured sensory neu- rons[J]. J Neurosci, 1995, 15(7): 4918-4926.
  • 2GILLESPIE LN, CLARK GM, MARZELLA PL. Delayed neu- rotrophin treatment supports auditory neuron survival" in deaf guinea pigs[J]. Neuroreport, 2004, 15(7): 1121- 1125.
  • 3SOMEYA S, XU J, KONDO K, et al. Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis [J]. Proc Natl Acad Sci USA, 2009, 106 (46): 19432-19437.
  • 4FRIEDMAN RA, VAN LAER L, HUENTELMAN M J, et al. GRM7 variants confer" susceptibility to age-related hearing im- pairment[J]. Hum Mol Genet, 2009, 18(4): 785-796.
  • 5GOPINATH B, FLOOD VM, ROCHTCHINA E, et al. Serum homocysteine and folate concentrations are associated with prevalent age-related hearing loss [J]. The Journal of Nutrition, 2009, 140(8):1469-1474.
  • 6SCHW&NDER M, XIONG W, TOKITA J, et al. A mouse mod- el for nonsyndromic deafness (DFNB12) links hearing loss to defects in tip links of mechanosensory hair cells [J]. PNAS, 2009, 106(13): 5252-5257.
  • 7RAMIREZ JJ, CALDWELL JL, MAJURE M, et al. Adeno-as- sociated virus vector expressing nerve growth factor enhances cholinergic axonal spouting after cortical injury in rats [J]. J Neurosci, 2003, 23(7): 2797-2803.
  • 8TUSZYNSKI MH, THAL L, PAY M, et al. A phase i clinical trial of nerve growth factor gene therapy for Alzheimer disease [J]. Nat Med, 2005, 11(5):551-555.
  • 9NIEWIADOMSKA G, KOMOROWSKI S, BAKSALERS- KA-PAZERA M. Amelioration of eholinergic neurons dysfunction in aged rats depends on the continuous supply of NGF [J]. Neu- robiol Aging, 2002, 23(4):601-613.
  • 10DE ROSA R, GARCIA AA, BRASCHI C, et al. Intranasal ad- ministration of nerve growth factor (NGF) rescues recognition memory deficits in ADII anti-NGF transgenic mice[J]. Proc Natl Acad Sci USA, 2005, 102(10):3811-3816.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部